Amy Hsu, MD, MS

The Influence of Body Mass Index on Outcomes and the Benefit of Antiplatelet Therapy following Percutaneous Coronary Interventio

08/01/2008

Amy Hsu , MD, MS;

Steven R. Steinhubl , MD;

Eric J. Topol , MD;

Robert V. Kelly , MD;

Obesity affects over 20% of the U.S. population and most countries in the developing world.1,2 It is an independent risk factor for premature coronary artery disease and is associated with an increase in cardiac morbidity and mortality,...

Obesity affects over 20% of the...

08/01/2008

Journal of Invasive Cardiology

Original Contribution

Timing and Correlates of Very Early Major Adverse Clinical Events Following Percutaneous Coronary Intervention

08/01/2008

Peter B. Berger , MD;

James L. Orford , MBChB, MPH, MD;

Joseph Jozic , MD;

Amy Hsu , MD, MS;

Steven R. Steinhubl , MD;

Eric J. Topol , MD;

The timing of, and risk factors for, very early (< 24 hours) major adverse clinical events (death, myocardial infarction [MI], urgent target vessel revascularization [uTVR], and major bleeding) following percutaneous coronary intervention...

The timing of, and risk factors...

08/01/2008

Journal of Invasive Cardiology